Anixa Biosciences Announces 2026 Annual Meeting of Stockholders and Corporate Update on Recent Clinical and Regulatory Progress

Anixa Biosciences will host its 2026 Annual Meeting of Stockholders on March 10, 2026, in a virtual format. The meeting will feature a presentation by Dr. Amit Kumar on recent clinical and regulatory progress, including survival observations and dose escalation in the ovarian cancer CAR-T trial, and final Phase 1 data from the breast cancer vaccine program. The presentation will be followed by a live Q&A session. The meeting will be open to all interested parties, including non-stockholders.